EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protective effect of Cyclo(His‐Pro) on peritoneal fibrosis through regulation of HDAC3 expression

Ji Eun Kim iD, Dohyun Han iD, Kyu Hong Kim iD, Areum Seo iD, Jong Joo Moon iD, Jin Seon Jeong iD, Ji Hye Kim iD, Eunjeong Kang iD, Eunjin Bae iD, Yong Chul Kim iD, Jae Wook Lee iD, Ran-Hui Cha iD und 5 weitere

The FASEB Journal · 2024

DOI: 10.1096/fj.202400854r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Ji Eun Kim und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Histone Deacetylases, Peritoneal Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Seoul National University Hospital (SNUH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal dialysis is a common treatment for end‐stage renal disease, but complications often force its discontinuation. Preventive treatments for peritoneal inflammation and fibrosis are currently lacking. Cyclo(His‐Pro) (CHP), a naturally occurring cyclic dipeptide, has demonstrated protective effects in various fibrotic diseases, yet its potential role in peritoneal fibrosis (PF) remains uncertain. In a mouse model of induced PF, CHP was administered, and quantitative proteomic analysis using liquid chromatography–tandem mass spectrometry was employed to identify PF‐related protein signaling pathways. The results were further validated using human primary cultured mesothelial cells. This analysis revealed the involvement of histone deacetylase 3 (HDAC3) in the PF signaling pathway. CHP administration effectively mitigated PF in both peritoneal tissue and human primary cultured mesothelial cells, concurrently regulating fibrosis‐related markers and HDAC3 expression. Moreover, CHP enhanced the expression of nuclear factor erythroid 2‐related factor 2 (Nrf2) while suppressing forkhead box protein M1 (FOXM1), known to inhibit Nrf2 transcription through its interaction with HDAC3. CHP also displayed an impact on spleen myeloid‐derived suppressor cells, suggesting an immunomodulatory effect. Notably, CHP improved mitochondrial function in peritoneal tissue, resulting in increased mitochondrial membrane potential and adenosine triphosphate production. This study suggests that CHP can significantly prevent PF in peritoneal dialysis patients by modulating HDAC3 expression and associated signaling pathways, reducing fibrosis and inflammation markers, and improving mitochondrial function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DeacetylasesPeritoneal FibrosisAnimalsMiceHumansMaleMice, Inbred C57BLSignal TransductionPeritoneal DialysisPeritoneumHistone Deacetylase 3

Stichwörter der Autor:innen

Cyclo(His‐Pro)HDAC3dialysismitochondriaperitoneal fibrosis

Substanzen

Histone DeacetylasesHistone Deacetylase 3

Autor:innen und Institutionen

  • Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Proteomics Core Facility, Seoul National University Hospital, Seoul, Korea.
  • Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
  • Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Korea.

ORCID-Profile: Ji Eun Kim, Dohyun Han, Kyu Hong Kim, Areum Seo, Jong Joo Moon, Jin Seon Jeong, Ji Hye Kim, Eunjeong Kang, Eunjin Bae, Yong Chul Kim, Jae Wook Lee, Ran-Hui Cha, Dong Ki Kim, Kook-Hwan Oh, Yon Su Kim, Hoe-Yune Jung, Seung Hee Yang

Förderung

  • Seoul National University Hospital (SNUH)

Zitieren

APA

Kim, J. E., Han, D., Kim, K. H., Seo, A., Moon, J. J., Jeong, J. S., Kim, J. H., Kang, E., Bae, E., Kim, Y. C., Lee, J. W., Cha, R. H., Kim, D. K., Oh, K. H., Kim, Y. S., Jung, H. Y., & Yang, S. H. (2024). Protective effect of Cyclo(His‐Pro) on peritoneal fibrosis through regulation of HDAC3 expression. The FASEB Journal. https://doi.org/10.1096/fj.202400854r

Vancouver

Kim JE, Han D, Kim KH, Seo A, Moon JJ, Jeong JS, et al. Protective effect of Cyclo(His‐Pro) on peritoneal fibrosis through regulation of HDAC3 expression. The FASEB Journal. 2024. doi:10.1096/fj.202400854r

BibTeX
@article{Kim2024,
  author = {Kim, Ji Eun and Han, Dohyun and Kim, Kyu Hong and Seo, Areum and Moon, Jong Joo and Jeong, Jin Seon and Kim, Ji Hye and Kang, Eunjeong and Bae, Eunjin and Kim, Yong Chul and Lee, Jae Wook and Cha, Ran-Hui and Kim, Dong Ki and Oh, Kook-Hwan and Kim, Yon Su and Jung, Hoe-Yune and Yang, Seung Hee},
  title = {Protective effect of Cyclo(His‐Pro) on peritoneal fibrosis through regulation of HDAC3 expression},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202400854r}
}
Kostenlos starten →